Enzyme/ROS dual-sensitive nanoplatform with on-demand Celastrol release capacity for enhanced ulcerative colitis therapy by ROS scavenging, microbiota rebalancing, inflammation alleviating.

MLA

Shi, Jinfeng, et al. “Enzyme/ROS Dual-Sensitive Nanoplatform with on-Demand Celastrol Release Capacity for Enhanced Ulcerative Colitis Therapy by ROS Scavenging, Microbiota Rebalancing, Inflammation Alleviating.” Journal of Nanobiotechnology, vol. 22, no. 1, July 2024, pp. 1–18. EBSCOhost, https://doi.org/10.1186/s12951-024-02725-9.

APA

Shi, J., Zhou, J., Liu, B., Lin, K., Xie, X., Han, X., Sheng, Y., Liu, Y., He, C., Zhou, Y., Zhu, N., Yang, Q., Luo, R., & Li, Y. (2024). Enzyme/ROS dual-sensitive nanoplatform with on-demand Celastrol release capacity for enhanced ulcerative colitis therapy by ROS scavenging, microbiota rebalancing, inflammation alleviating. Journal of Nanobiotechnology, 22(1), 1–18. https://doi.org/10.1186/s12951-024-02725-9

Chicago

Shi, Jinfeng, Jiahui Zhou, Bo Liu, Kezhou Lin, Xingliang Xie, Xue Han, Yanmei Sheng, et al. 2024. “Enzyme/ROS Dual-Sensitive Nanoplatform with on-Demand Celastrol Release Capacity for Enhanced Ulcerative Colitis Therapy by ROS Scavenging, Microbiota Rebalancing, Inflammation Alleviating.” Journal of Nanobiotechnology 22 (1): 1–18. doi:10.1186/s12951-024-02725-9.